General General News

Pension Funds Identified as Key Players in Combating Antimicrobial Resistance

Seoul:Pension funds are emerging as vital contributors in the battle against antimicrobial resistance (AMR), leveraging their significant financial influence to impact corporate approaches to this global challenge.

According to World Economic Forum, these funds control tens of trillions of dollars globally, providing them with substantial power over the companies in which they invest. This includes the ability to influence corporate governance and strategic responses to issues such as AMR.

The connection between pension funds and AMR is highlighted by their investment in sectors like pharmaceuticals, agrifood, and water utilities. As major shareholders, they can drive changes in how these sectors address antimicrobial resistance, potentially affecting everything from drug development to agricultural practices.

AMR is recognized as a systemic risk with significant economic implications, as poor health can hamper productivity and economic growth. The persistence of AMR, characterized by microbes resisting treatment, poses long-term risks to sectors critical to modern medicine, including cancer care.

Investors, through stewardship and shareholder influence, can compel companies to adopt practices that mitigate AMR. An example is the collaboration between Legal and General and Amundi, which sought to ensure McDonald's supply chain adheres to WHO guidelines on antimicrobial use.

While investors have a crucial role, AMR cannot be tackled by them alone. Effective public policy, scientific research, and international cooperation remain essential. The diversified portfolios of pension funds reflect their vested interest in the health of the global economy, extending beyond individual companies to systemic economic stability.

The World Economic Forum emphasizes that with their vast capital and influence, pension funds could be pivotal in fostering global health resilience against AMR.